Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Drug Resistance

Free Subscription 12.01.2026 2 AIDS 5 Antimicrob Agents Chemother 7 Clin Infect Dis 3 Emerg Infect Dis 9 Int J Antimicrob Agents 1 J Infect Chemother 1 N Engl J Med 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. KOVALENKO G, Liulchuk MG, Filippovych M, Smyrnov P, et al
   VANTAGE: van-based real-time HIV sequencing for transmission mapping and drug resistance profiling in war-affected Ukraine.
   AIDS. 2026;40:123-126.
   PubMed         Abstract available
   
   
2. SOULIE C, Balde A, Fofana D, Charpentier C, et al
   No evidence of an effect of the M184I/V on the doravirine/lamivudine/tenofovir switch efficacy in people living with HIV.
   AIDS. 2025 Sep 8. doi: 10.1097/QAD.0000000000004339.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

3. CASTANHEIRA M, Kimbrough JH, Morgan GM, Karr M, et al
   Activity of aztreonam-avibactam, cefiderocol, and cefepime-taniborbactam against a global collection of genetically characterized metallo-beta-lactamase-producing Enterobacterales.
   Antimicrob Agents Chemother. 2026;70:e0084225.
   PubMed         Abstract available
   
   
4. LACKNER M, Toepfer S, Keniya MV, Lax C, et al
   The molecular basis of intrinsic resistance to azoles in Rhizopus arrhizus.
   Antimicrob Agents Chemother. 2026;70:e0133725.
   PubMed         Abstract available
   
   
5. YOUSSEF EG, Gebremariam T, Gu Y, Patterson H, et al
   Efficacy assessments of EL219, a next-generation polyene antifungal, in immunosuppressed mice infected with drug-sensitive and drug-resistant Aspergillus isolates.
   Antimicrob Agents Chemother. 2025 Dec 5:e0140025. doi: 10.1128/aac.01400.
   PubMed         Abstract available
   
   
6. VAN HELDEN SR, Bleick CR, Holger DJ, El Ghali A, et al
   Impact of Pseudomonas aeruginosa biofilm exopolysaccharide composition on bacteriophage and bacteriophage-antibiotic combination activity.
   Antimicrob Agents Chemother. 2026;70:e0092525.
   PubMed         Abstract available
   
   
7. VARIK V, Wang G, Kritikos G, Banzhaf M, et al
   Synergistic activity of rifampicin and polymyxin B against intracellular Gram-negative ESKAPE pathogens involves bacterial membrane alterations and enhanced oxidative damages.
   Antimicrob Agents Chemother. 2026;70:e0131925.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

8. ADAMSON PC, David HM, Pham LQ, Bui HTM, et al
   Cefixime for the Treatment of Neisseria gonorrhoeae Infections in a Setting With Increased Antimicrobial Resistance: A Retrospective Study in Hanoi, Vietnam.
   Clin Infect Dis. 2026;81.
   PubMed         Abstract available
   
   
9. KLINE MC, Oliveira Roster K, Helekal D, Rumpler E, et al
   Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study.
   Clin Infect Dis. 2026;81.
   PubMed         Abstract available
   
   
10. FAGAN L, Alexander S, Fifer H
    The Invisible Tide of Neisseria gonorrhoeae Treatment Failures: A Review and Commentary.
    Clin Infect Dis. 2026;81.
    PubMed         Abstract available
    
    
11. HSU KK, Ivanof C, Gallagher MC, Worrall DP, et al
    How Public Health Surveillance Systems Can Contribute to Antimicrobial Resistance Prevention: The Massachusetts Experience.
    Clin Infect Dis. 2026;81.
    PubMed         Abstract available
    
    
12. VAN DER VEEN S, Sun X, Ge H, Chau TM, et al
    PenA Alleles Associated With Gonococcal Ceftriaxone Resistance in Cambodia, China, and Vietnam.
    Clin Infect Dis. 2026;81.
    PubMed         Abstract available
    
    
13. MELENDEZ JH, Manabe YC
    Current and Emerging Approaches and Technologies for Rapid Detection of Neisseria gonorrhoeae Antimicrobial Resistance.
    Clin Infect Dis. 2026;81.
    PubMed         Abstract available
    
    
14. ALLAN-BLITZ LT, Klausner JD
    Treatment Diversification to Address the Continued Rise of Antimicrobial Resistance in Neisseria gonorrhoeae.
    Clin Infect Dis. 2026;81.
    PubMed        
    
    

    
    Emerg Infect Dis

15. FATIMA Z, Jayaratne P, Arrabi A, Rutherford C, et al
    Macrolide Resistance and P1 Cytadhesin Genotyping of Mycoplasma pneumoniae during Outbreak, Canada, 2024-2025.
    Emerg Infect Dis. 2025;31:2316-2319.
    PubMed         Abstract available
    
    
16. SIMON S, Trost E, Lennings J, Enkelmann J, et al
    Carbapenem-Resistant Salmonella Typhi Infection in Traveler Returning to Germany from India, 2024.
    Emerg Infect Dis. 2025;31:2335-2338.
    PubMed         Abstract available
    
    
17. WANG H, Embry T, Everhart K, Szekely M, et al
    Macrolide-Resistant Mycoplasma pneumoniae in Children, Ohio, USA.
    Emerg Infect Dis. 2025;31:2341-2343.
    PubMed         Abstract available
    
    

    
    Int J Antimicrob Agents

18. LI J, Fan J, Tan Z, Li A, et al
    NucS Thr74Ile confers mutator phenotype in a globally disseminated clinical Mycobacterium abscessus subsp. abscessus clone.
    Int J Antimicrob Agents. 2026;67:107677.
    PubMed         Abstract available
    
    
19. LIM C, Coombs GW, Mowlaboccus S
    Molecular mechanisms of resistance and tolerance of Staphylococcus aureus to daptomycin.
    Int J Antimicrob Agents. 2026;67:107678.
    PubMed         Abstract available
    
    
20. JAN HE, Wang JL, Lee NY, Hsueh SC, et al
    Ceftazidime-avibactam resistance among clinical isolates of Citrobacter freundii, Morganella morganii, Providencia spp. and Serratia marcescens across five continents: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme,
    Int J Antimicrob Agents. 2026;67:107669.
    PubMed         Abstract available
    
    
21. LOMBARDI F, Cacciola EG, Carli F, Saladini F, et al
    Impact of DNA-stored mutations on virological response in virologically suppressed PWH in the switch to modern regimens.
    Int J Antimicrob Agents. 2026;67:107670.
    PubMed         Abstract available
    
    
22. HONG R, Xu P, Lai W, Wu C, et al
    Discrepancy between WGS-based genotypic and phenotypic drug susceptibility testing of first and second-line drugs for Mycobacterium tuberculosis: Limited impact of unknown resistance mechanisms.
    Int J Antimicrob Agents. 2026;67:107666.
    PubMed         Abstract available
    
    
23. WU Y, Yu Y, He X, Mao W, et al
    Genome-wide insight into the evolution and global transmission of tigecycline resistant tet(X4)-carrying Klebsiella species across reservoirs.
    Int J Antimicrob Agents. 2026;67:107665.
    PubMed         Abstract available
    
    
24. LU Y, Yu X, Pan Y, Yin H, et al
    Antimicrobial peptide CATH-1 combats Streptococcus suis by targeting serine/threonine kinase.
    Int J Antimicrob Agents. 2026;67:107656.
    PubMed         Abstract available
    
    
25. XU T, Zhou Y, Xu Q, Wang L, et al
    ATP-binding cassette transporters mediate and regulate metronidazole resistance in Clostridioides difficile.
    Int J Antimicrob Agents. 2026 Jan 3:107709.
    PubMed         Abstract available
    
    
26. KOIZUMI R, Tsuzuki S, Asai Y, Aoyagi K, et al
    Corrigendum to "Impact of antimicrobial resistance measures and the emergence of COVID-19 on antimicrobial use throughout the Japanese population: A retrospective cohort study using a national claims database" [International Journal of Antimicrobial A
    Int J Antimicrob Agents. 2026 Jan 3:107694.
    PubMed        
    
    

    
    J Infect Chemother

27. MATSUI K, Sakurai A, Matsumura Y, Hosoda T, et al
    In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in Japan.
    J Infect Chemother. 2026 Jan 6:102905. doi: 10.1016/j.jiac.2026.102905.
    PubMed         Abstract available
    
    

    
    N Engl J Med

28. HOWIE RL, Sharma S, Kyle JL, Rubis AB, et al
    Serogroup Switching in Neisseria meningitidis with Dual Antibiotic Resistance.
    N Engl J Med. 2026;394:199-201.
    PubMed        
    
    

    
    PLoS One

29. ABDELHAMED H, Riman MM, Arick MA 2nd, Dawood AS, et al
    Investigation mechanisms of action and resistance of Edwardsiella ictaluri to trans-cinnamaldehyde.
    PLoS One. 2026;21:e0340053.
    PubMed         Abstract available
    
    
30. MUSEE HK, Mukhebi DW
    Genetic diversity, genetic population structure and epidemiology of multidrug resistance Neisseria gonorrhoeae from Kenya.
    PLoS One. 2026;21:e0339395.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.